Commentary | Published:

Emerging ethical issues in neuroscience

Nature Neuroscience volume 5, pages 11231129 (2002) | Download Citation

Subjects

There is growing public awareness of the ethical issues raised by progress in many areas of neuroscience. This commentary reviews the issues, which are triaged in terms of their novelty and their imminence, with an exploration of the relevant ethical principles in each case.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Brain Policy: How the New Neuroscience Will Change Our Lives and Our Politics (Georgetown Univ. Press, Washington, DC, 1999).

  2. 2.

    Our Posthuman Future (Farrar, Straus & Giroux, New York, 2002).

  3. 3.

    On the functions of lithium: the mood stabilizer. Bioessays 19, 199–200 (1997).

  4. 4.

    Listening to Prozac (Penguin, New York, 1993).

  5. 5.

    , & The continuity of depression in clinical and nonclinical samples. Psychol. Bull. 121, 395–416 (1997).

  6. 6.

    Mood disorders in the female patient. Int. J. Fertility Women's Med. 42, 67–72 (1997).

  7. 7.

    , , & in Neurobiology of Mental Illness (eds. Charney, D. S., Nestler, E. J. & Bunney, B. S.) 419–432 (Oxford University Press, New York, 1999).

  8. 8.

    et al. Selective alteration of personality and social behavior by serotonergic intervention. Am. J. Psychiatry 155, 373–379 (1998).

  9. 9.

    & Serotonergic intervention affects both social dominance and affiliative behaviour. Psychopharmacology 161, 324–330 (2002).

  10. 10.

    et al. Effects of methylphenidate on spatial working memory and planning in healthy young adults. Psychopharmacology 131, 196–206 (1997).

  11. 11.

    The run on Ritalin: Attention deficit disorder and stimulant treatment in the 1990s. Hastings Center Report 26, 12–14 (1996).

  12. 12.

    & Student perceptions of methylphenidate abuse at a public liberal arts college. J. Am. College Health 49, 143–5 (2000).

  13. 13.

    The Adaptive Characteristics of Thought (Erlbaum, Hillsdale, New Jersey, 1990).

  14. 14.

    The Mind of a Mnemonist (Harvard Univ. Press, Cambridge, Massachusetts, 1968).

  15. 15.

    , & Why there are complementary learning systems in the hippocampus and neocortex: Insights from the successes and failures of connectionist models of learning and memory. Psychol. Rev. 102, 419–457 (1995).

  16. 16.

    & The Handbook of Aging and Cognition (Erlbaum, Hillsdale, New Jersey, 1992).

  17. 17.

    , , , & Ginkgo for memory enhancement: a randomized controlled trial. JAMA 288, 835–840 (2002).

  18. 18.

    et al. Enhancement by an ampakine of memory encoding in humans. Exp. Neurol. 146, 553–559 (1997).

  19. 19.

    , , , & Interest of modafinil, a new psychostimulant, during a sixty-hour sleep deprivation experiment. Fund. Clin. Pharmacol. 9, 1–9 (1995).

  20. 20.

    , , & A double-blind, placebo-controlled investigation of the efficacy of modafinil for sustaining the alertness and performance of aviators: a helicopter simulator study. Psychopharmacology 150, 272–282 (2000).

  21. 21.

    & Pharmacologic options for the treatment of obesity. Am. J. Health System Pharmacol. 58, 1301–1308 (2001).

  22. 22.

    , & Direct sale of sildenafil (Viagra) to consumers over the internet. New Engl. J. Med. 341, 1389–1392 (1999).

  23. 23.

    Enhancing Human Traits: Ethical and Social Implications (Georgetown Univ. Press, Washington, DC, 1998).

  24. 24.

    , & Serotonin function and antiaggressive responsive to fluoxetine: a pilot study. Biol. Psychiatry 42, 546–552 (1997).

  25. 25.

    , , & Effects of chronic paroxetine administration on measures of aggressive and impulsive responses of adult males with a history of conduct disorder. Psychopharmacology 159, 266–274 (2002).

  26. 26.

    et al. Aggression, impulsivity, and central nervous system seretonergic responsivity in a nonpatient sample. Neuropsychopharmacology 19, 287–299 (1998).

  27. 27.

    & Selective serotonin reuptake inhibitors and violence: a review of the available evidence. Acta Psychiatry Scand. 104, 84–91 (2001).

  28. 28.

    & Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch. Gen. Psychiatry 54, 1081–1088 (1997).

  29. 29.

    et al. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. J. Clin. Psychopharmacol. 15, 23–29 (1995).

  30. 30.

    , & Are sex offenders treatable? A research overview. Psychiatric Services 50, 349–361 (1999).

  31. 31.

    Diagnostic and Statistical Manual of Mental Disorders IV-R (American Psychiatric Assoc., Washington, DC, 1994).

  32. 32.

    Hooked on hype: addiction and responsibility. Law Philos. 19, 3–49, (2000).

  33. 33.

    et al. Dopamine transporter density in patients with attention deficit hyperacivity disorder. Lancet 354, 2132–2133 (1999).

  34. 34.

    et al. Limbic activation during cue-induced cocaine craving. Am. J. Psychiatry 156, 11–18 (1999).

  35. 35.

    et al. Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am. J. Psychiatry 157, 1789–1798 (2000).

  36. 36.

    , , & Neural correlates of conscious self-regulation of emotion. J. Neurosci. 21, 1–6 (2001).

  37. 37.

    & Neuroimaging of emotion and personality: Scientific evidence and ethical considerations. Brain Cogn. (in press).

  38. 38.

    , , , & Differential response in the human amygdala to racial outgroup versus ingroup face stimuli. Neuroreport 11, 2351–2355 (2000).

  39. 39.

    et al. Performance on indirect measures of race evaluation predicts amygdala activation. J. Cogn. Neurosci. 12, 729–738 (2000).

  40. 40.

    et al. Brain activity during simulated deception: an event-related functional magnetic resonance study. Neuroimage 15, 727–732 (2002).

  41. 41.

    Is it time to abandon brain death? Hastings Center Report 27, 29–37 (1997).

  42. 42.

    The Engine of Reason, the Seat of the Soul: A Philosophical Journey into the Brain (MIT Press, Cambridge, Massachusettts, 1995).

  43. 43.

    Ethical and human rights issues in research on mental disorders that may affect decision-making capacity. New Engl. Jl Med. 340, 1430–1434 (1999).

  44. 44.

    Great and Desperate Cures: The Rise and Decline of Psychosurgery and Other Radical Treatments for Mental Illness (Basic, New York, 1986).

  45. 45.

    & Novel physical treatments for the management of neuropsychiatric disorders. J. Psychosom. Res. 53, 709–719 (2002).

  46. 46.

    & Neurosurgery for psychiatric disorders. J. Neurol. Neurosurg. Psychiatry 63, 701–705 (1997).

  47. 47.

    , & Transcranial magnetic stimulation: A neuropsychiatric tool for the 21st century. J. Neuropsychiatry Clin. Neurosci. 8, 373–382 (1996).

  48. 48.

    , , , & Can medial temporal regions distinguish true from false? Proc. Natl. Acad. Sci. USA 98, 4805–4810 (2001).

  49. 49.

    et al. Reduced prefrontal and increased subcortical brain functioning assessed using positron emission tomography in predatory and affective murderers. Behav. Sci. Law 16, 319–332 (1998).

  50. 50.

    et al. An fMRI investigation of emotional engagement in moral judgement. Science 293, 2105–2108 (2001).

  51. 51.

    , , , & A functional imagng study of cooperation in two-person reciprocal exchange. Proc. Natl. Acad. Sci. USA 98, 11832–11835 (2001)

  52. 52.

    & Mental imagery of faces and places activates corresponding stimulus-specific brain regions. J. Cogn. Neurosci. 12, 1013–1023 (2000).

Download references

Author information

Affiliations

  1. Martha Farah is at the Center for Cognitive Neuroscience, University of Pennsylvania, 3815 Walnut St., Philadelphia, Pennsylvania 19104-6196, USA. mfarah@psych.upenn.edu

    • Martha J. Farah

Authors

  1. Search for Martha J. Farah in:

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nn1102-1123

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing